Drugs / CVXL-0107
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02641054 | Feb 2016 → Jun 2017 | Parkinson disease | CleveXel Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CVXL-0107 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02641054 ↗ |